PRGO - Perrigo Company plc
| Previous Close | 48.58 |
| Open | 48.31 |
| Bid | 40.50 x 900 |
| Ask | 49.97 x 800 |
| Day's Range | 47.08 - 48.52 |
| 52 Week Range | 36.28 - 84.94 |
| Volume | 751,898 |
| Avg. Volume | 1,607,403 |
| Market Cap | 6.42B |
| Beta (3Y Monthly) | 1.88 |
| PE Ratio (TTM) | 49.74 |
| EPS (TTM) | 0.95 |
| Earnings Date | May 6, 2019 - May 10, 2019 |
| Forward Dividend & Yield | 0.76 (1.56%) |
| Ex-Dividend Date | 2019-02-28 |
| 1y Target Est | 62.40 |
- GlobeNewswire•2 days ago
Sol-Gel Technologies Reports Full Year 2018 Financial Results and Provides Corporate Update
Company met all milestones in 2018 and this year expects to report Phase III top-line results for Epsolay® and TWIN, potentially best-in-class papulopustular rosacea and acne.
- PR Newswire•3 days ago
Perrigo Appoints Seasoned CPG Veteran Ray Silcock As Chief Financial Officer
TASE: PRGO) today announced that Ray Silcock will join the Company as Executive Vice President and Chief Financial Officer, effective March 25, 2019. Ray will lead the global finance, tax, internal audit, investor relations, corporate communications, business development and treasury functions. Mr. Silcock joins Perrigo having been CFO of both public and private equity held companies for over 20 years.
- PR Newswire•5 days ago
Perrigo Announces Tentative FDA Approval For The Generic Version Of Finacea® Foam, 15%
DUBLIN , March 18, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) a leading global provider of "Quality, Affordable, Self-Care Products™" today announced it has received tentative approval ...
- Markit•11 days ago
See what the IHS Markit Score report has to say about Perrigo Company PLC.
Perrigo Company PLC NYSE:PRGOView full report here! Summary * Bearish sentiment is moderate Bearish sentimentShort interest | NeutralShort interest is moderate for PRGO with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold PRGO had net inflows of $2.80 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- GlobeNewswire•16 days ago
Recent Analysis Shows Veeva, Mobile TeleSystems OJSC, Jacobs Engineering Group, Perrigo Company plc, AstraZeneca, and Primoris Services Market Influences — Renewed Outlook, Key Drivers of Growth
NEW YORK, March 07, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
- PR Newswire•18 days ago
Perrigo Confirms Patent Challenge for Generic Version of Nascobal®
TASE) today announced that Endo Pharmaceuticals Inc. initiated patent litigation on March 1, 2019 in the United States District Court for the District of Delaware regarding Perrigo's Paragraph IV Abbreviated New Drug Application for cyanocobalamin nasal spray 500mcg, asserting patents listed in the Orange Book for Nascobal®. Perrigo Executive Vice President and President Rx Pharmaceuticals Sharon Kochan stated, "This ANDA filling and subsequent patent challenge further demonstrates our commitment to enhance our pipeline and product offering in the extended topical space. Perrigo Company is dedicated to making lives better by bringing high "Quality, Affordable Self-care Products™" that consumers trust everywhere they are sold. The Company is a leading provider of over-the-counter health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. Visit Perrigo online at (http://www.perrigo.com).
- Thomson Reuters StreetEvents•19 days ago
Edited Transcript of PRGO earnings conference call or presentation 27-Feb-19 9:30pm GMT
Q4 2018 Perrigo Company PLC Earnings Call
- ACCESSWIRE•19 days ago
Final Deadline - Perrigo Company plc (PRGO) Bronstein, Gewirtz & Grossman, LLC
NEW YORK, NY / ACCESSWIRE / March 4, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors with losses exceeding $25K that a class action lawsuit has been filed against Perrigo Company plc ("Perrigo" ...
- GlobeNewswire•19 days ago
DEADLINE TODAY: UPDATE for YRCW, PRGO and YRIV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, March 04, 2019 -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies..
- ACCESSWIRE•20 days ago
Final Deadline Alert - Perrigo Company plc (PRGO) Bronstein, Gewirtz & Grossman, LLC
NEW YORK, NY / ACCESSWIRE / March 3, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors with losses exceeding $25K that a class action lawsuit has been filed against Perrigo Company plc ("Perrigo" ...
- ACCESSWIRE•20 days ago
DEADLINE ALERT - YRCW, PRGO & CNTF - - Bronstein, Gewirtz & Grossman, LLC
NEW YORK, NY / ACCESSWIRE / March 3, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed againstthe following publicly-traded companies. You can review ...
- Business Wire•20 days ago
PERRIGO INVESTOR ALERT: Rosen Law Firm Reminds Perrigo Company plc Investors of Important March 4, 2019 Deadline in Securities Class Action Lawsuit – PRGO
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Perrigo Company plc from November 8, 2018 through December 20, 2018, inclusive of the important March 4, 2019 deadline in the securities class action lawsuit filed against the company.
- GlobeNewswire•22 days ago
SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Perrigo Company plc - March 4 Deadline – PRGO
Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Perrigo Company plc (PRGO) from November 8, 2018 through December 20, 2018, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Perrigo investors under the federal securities laws. To join the Perrigo class action, go to http://pawarlawgroup.com/cases/perrigo-company-plc/ or call Vik Pawar, Esq.
- GlobeNewswire•22 days ago
SHAREHOLDER ALERT: DNKEY YRCW SOGO PRGO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, March 01, 2019 -- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a.
- ACCESSWIRE•23 days ago
Perrigo Company plc (PRGO) Bronstein, Gewirtz & Grossman, LLC Class Action Update and Deadline -- March 4, 2019
NEW YORK, NY / ACCESSWIRE / February 28, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Perrigo Company plc ("Perrigo" or the "Company") ...
- ACCESSWIRE•23 days ago
Perrigo Company plc (PRGO) Bronstein, Gewirtz & Grossman, LLC Class Action Update & Lead Plaintiff Deadline -- March 4, 2019
NEW YORK, NY / ACCESSWIRE / February 28, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Perrigo Company plc ("Perrigo" or the "Company") ...
- GlobeNewswire•23 days ago
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of YRCW, PRGO, AVEO and CVS
NEW YORK, Feb. 28, 2019 -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a.
- Zacks•23 days ago
Perrigo (PRGO) Q4 Earnings Miss, Sales Beat, Stock Down
Perrigo (PRGO) reports wider loss in fourth-quarter 2018. However, sales were marginally higher. Challenges in the Rx segment continues to hurt the top line.
- ACCESSWIRE•23 days ago
YRCW, PRGO & CNTF - Class Action Reminder - Bronstein, Gewirtz & Grossman, LLC
NEW YORK, NY / ACCESSWIRE / February 28, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can ...
Motley Fool•24 days agoPerrigo Company PLC (PRGO) Q4 2018 Earnings Conference Call Transcript
PRGO earnings call for the period ending December 31, 2018.
- MarketWatch•24 days ago
Perrigo stock declines after hours as earnings miss
Perrigo Co. shares fell in the extended session Wednesday after the company's quarterly earnings missed Wall Street estimates. Perrigo shares fell 4.6% after hours, following a 2.6% decline to close the regular session at $47.06. The company reported fourth-quarter net income of $82 million, or 60 cents a share, compared with $73 million, or 52 cents a share, in the year-ago period. Adjusted earnings were 97 cents a share. Revenue fell to $1.2 billion from $1.28 billion in the year-ago quarter. Analysts surveyed by FactSet had forecast earnings of $1 a share on revenue of $1.18 billion.
- PR Newswire•24 days ago
Perrigo Company plc Reports Fourth Quarter And Full-Year 2018 Financial Results
DUBLIN , Feb. 27, 2019 /PRNewswire/ -- Full-year 2018 GAAP ("Reported") net sales of $4.7 billion , reflecting a 4% decline versus a year ago; Fourth quarter 2018 reported net sales of $1.2 billion ...
- ACCESSWIRE•24 days ago
Perrigo Company plc (PRGO) Update Bronstein, Gewirtz & Grossman, LLC Class Action & Lead Plaintiff Deadline -- March 4, 2019
NEW YORK, NY / ACCESSWIRE / February 27, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Perrigo Company plc ("Perrigo" or the "Company") ...
- GlobeNewswire•24 days ago
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of DNKEY, ARLO, SOGO and PRGO
The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses. If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court.
- ACCESSWIRE•24 days ago
Perrigo Company plc (PRGO) Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action & Lead Plaintiff Deadline -- March 4, 2019
NEW YORK, NY / ACCESSWIRE / February 27, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Perrigo Company plc ("Perrigo" or the "Company") ...
